According to this latest study, the 2021 growth of Glucagon will have significant change from previous year. By the most conservative estimates of global Glucagon market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 512.6 million in 2020. Over the next five years the Glucagon market will register a 6.3% CAGR in terms of revenue, the global market size will reach US$ 655.2 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Glucagon market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Inject Glucagon
Nasal Glucagon
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Taj Pharmaceuticals
Xeris Pharmaceuticals
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glucagon Consumption 2016-2026
2.1.2 Glucagon Consumption CAGR by Region
2.2 Glucagon Segment by Type
2.2.1 Inject Glucagon
2.2.2 Nasal Glucagon
2.3 Glucagon Sales by Type
2.3.1 Global Glucagon Sales Market Share by Type (2016-2021)
2.3.2 Global Glucagon Revenue and Market Share by Type (2016-2021)
2.3.3 Global Glucagon Sale Price by Type (2016-2021)
2.4 Glucagon Segment by Application
2.4.1 Emergency Kits
2.4.2 General Use
2.4.3 Diagnostic & Motility
2.4.4 Cardiogenic Shock
2.4.5 Others
2.5 Glucagon Sales by Application
2.5.1 Global Glucagon Sale Market Share by Application (2016-2021)
2.5.2 Global Glucagon Revenue and Market Share by Application (2016-2021)
2.5.3 Global Glucagon Sale Price by Application (2016-2021)
3 Global Glucagon by Company
3.1 Global Glucagon Sales Market Share by Company
3.1.1 Global Glucagon Sales by Company (2019-2021)
3.1.2 Global Glucagon Sales Market Share by Company (2019-2021)
3.2 Global Glucagon Revenue Market Share by Company
3.2.1 Global Glucagon Revenue by Company (2019-2021)
3.2.2 Global Glucagon Revenue Market Share by Company (2019-2021)
3.3 Global Glucagon Sale Price by Company
3.4 Global Manufacturers Glucagon Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glucagon Product Location Distribution
3.4.2 Players Glucagon Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Glucagon by Region
4.1 Global Glucagon by Region
4.1.1 Global Glucagon Sales by Region
4.1.2 Global Glucagon Revenue by Region
4.2 Americas Glucagon Sales Growth
4.3 APAC Glucagon Sales Growth
4.4 Europe Glucagon Sales Growth
4.5 Middle East & Africa Glucagon Sales Growth
5 Americas
5.1 Americas Glucagon Sales by Country
5.1.1 Americas Glucagon Sales by Country (2016-2021)
5.1.2 Americas Glucagon Revenue by Country (2016-2021)
5.2 Americas Glucagon Sales by Type
5.3 Americas Glucagon Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glucagon Sales by Region
6.1.1 APAC Glucagon Sales by Region (2016-2021)
6.1.2 APAC Glucagon Revenue by Region (2016-2021)
6.2 APAC Glucagon Sales by Type
6.3 APAC Glucagon Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Glucagon by Country
7.1.1 Europe Glucagon Sales by Country (2016-2021)
7.1.2 Europe Glucagon Revenue by Country (2016-2021)
7.2 Europe Glucagon Sales by Type
7.3 Europe Glucagon Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glucagon by Country
8.1.1 Middle East & Africa Glucagon Sales by Country (2016-2021)
8.1.2 Middle East & Africa Glucagon Revenue by Country (2016-2021)
8.2 Middle East & Africa Glucagon Sales by Type
8.3 Middle East & Africa Glucagon Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Glucagon Distributors
10.3 Glucagon Customer
11 Global Glucagon Market Forecast
11.1 Global Glucagon Forecast by Region
11.1.1 Global Glucagon Forecast by Regions (2021-2026)
11.2.2 Global Glucagon Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Glucagon Forecast by Type
11.7 Global Glucagon Forecast by Application
12 Key Players Analysis
12.1 Novo Nordisk
12.1.1 Novo Nordisk Company Information
12.1.2 Novo Nordisk Glucagon Product Offered
12.1.3 Novo Nordisk Glucagon Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Novo Nordisk Main Business Overview
12.1.5 Novo Nordisk Latest Developments
12.2 Eli Lilly
12.2.1 Eli Lilly Company Information
12.2.2 Eli Lilly Glucagon Product Offered
12.2.3 Eli Lilly Glucagon Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Eli Lilly Main Business Overview
12.2.5 Eli Lilly Latest Developments
12.3 Fresenius Kabi
12.3.1 Fresenius Kabi Company Information
12.3.2 Fresenius Kabi Glucagon Product Offered
12.3.3 Fresenius Kabi Glucagon Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Fresenius Kabi Main Business Overview
12.3.5 Fresenius Kabi Latest Developments
12.4 Torrent Labs
12.4.1 Torrent Labs Company Information
12.4.2 Torrent Labs Glucagon Product Offered
12.4.3 Torrent Labs Glucagon Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Torrent Labs Main Business Overview
12.4.5 Torrent Labs Latest Developments
12.5 Taj Pharmaceuticals
12.5.1 Taj Pharmaceuticals Company Information
12.5.2 Taj Pharmaceuticals Glucagon Product Offered
12.5.3 Taj Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Taj Pharmaceuticals Main Business Overview
12.5.5 Taj Pharmaceuticals Latest Developments
12.6 Xeris Pharmaceuticals
12.6.1 Xeris Pharmaceuticals Company Information
12.6.2 Xeris Pharmaceuticals Glucagon Product Offered
12.6.3 Xeris Pharmaceuticals Glucagon Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Xeris Pharmaceuticals Main Business Overview
12.6.5 Xeris Pharmaceuticals Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Glucagon Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Inject Glucagon
Table 3. Major Players of Nasal Glucagon
Table 4. Global Glucagon Sales by Type (2016-2021) & (K MT)
Table 5. Global Glucagon Sales Market Share by Type (2016-2021)
Table 6. Global Glucagon Revenue by Type (2016-2021) & ($ million)
Table 7. Global Glucagon Revenue Market Share by Type (2016-2021)
Table 8. Global Glucagon Sale Price by Type (2016-2021)
Table 9. Global Glucagon Sales by Application (2016-2021) & (K MT)
Table 10. Global Glucagon Sales Market Share by Application (2016-2021)
Table 11. Global Glucagon Value by Application (2016-2021)
Table 12. Global Glucagon Revenue Market Share by Application (2016-2021)
Table 13. Global Glucagon Sale Price by Application (2016-2021)
Table 14. Global Glucagon Sales by Company (2019-2021) & (K MT)
Table 15. Global Glucagon Sales Market Share by Company (2019-2021)
Table 16. Global Glucagon Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Glucagon Revenue Market Share by Company (2019-2021)
Table 18. Global Glucagon Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Glucagon Producing Area Distribution and Sales Area
Table 20. Players Glucagon Products Offered
Table 21. Glucagon Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Glucagon Sales by Region (2016-2021) (K MT)
Table 25. Global Glucagon Sales Market Share by Region (2016-2021)
Table 26. Global Glucagon Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Glucagon Revenue Market Share by Region (2016-2021)
Table 28. Americas Glucagon Sales by Country (2016-2021) & (K MT)
Table 29. Americas Glucagon Sales Market Share by Country (2016-2021)
Table 30. Americas Glucagon Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Glucagon Revenue Market Share by Country (2016-2021)
Table 32. Americas Glucagon Sales by Type (2016-2021) & (K MT)
Table 33. Americas Glucagon Sales Market Share by Type (2016-2021)
Table 34. Americas Glucagon Sales by Application (2016-2021) & (K MT)
Table 35. Americas Glucagon Sales Market Share by Application (2016-2021)
Table 36. APAC Glucagon Sales by Region (2016-2021) & (K MT)
Table 37. APAC Glucagon Sales Market Share by Region (2016-2021)
Table 38. APAC Glucagon Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Glucagon Revenue Market Share by Region (2016-2021)
Table 40. APAC Glucagon Sales by Type (2016-2021) & (K MT)
Table 41. APAC Glucagon Sales Market Share by Type (2016-2021)
Table 42. APAC Glucagon Sales by Application (2016-2021) & (K MT)
Table 43. APAC Glucagon Sales Market Share by Application (2016-2021)
Table 44. Europe Glucagon Sales by Country (2016-2021) & (K MT)
Table 45. Europe Glucagon Sales Market Share by Country (2016-2021)
Table 46. Europe Glucagon Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Glucagon Revenue Market Share by Country (2016-2021)
Table 48. Europe Glucagon Sales by Type (2016-2021) & (K MT)
Table 49. Europe Glucagon Sales Market Share by Type (2016-2021)
Table 50. Europe Glucagon Sales by Application (2016-2021) & (K MT)
Table 51. Europe Glucagon Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Glucagon Sales by Country (2016-2021) & (K MT)
Table 53. Middle East & Africa Glucagon Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Glucagon Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Glucagon Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Glucagon Sales by Type (2016-2021) & (K MT)
Table 57. Middle East & Africa Glucagon Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Glucagon Sales by Application (2016-2021) & (K MT)
Table 59. Middle East & Africa Glucagon Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Glucagon
Table 61. Key Application and Potential Industries of Glucagon
Table 62. Key Challenges of Glucagon
Table 63. Key Trends of Glucagon
Table 64. Glucagon Distributors List
Table 65. Glucagon Customer List
Table 66. Global Glucagon Sales Forecast by Region (2021-2026) & (K MT)
Table 67. Global Glucagon Consumption Market Forecast by Region
Table 68. Global Glucagon Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Glucagon Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Glucagon Sales Forecast by Country (2021-2026) & (K MT)
Table 71. Americas Glucagon Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Glucagon Sales Forecast by Region (2021-2026) & (K MT)
Table 73. APAC Glucagon Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Glucagon Sales Forecast by Country (2021-2026) & (K MT)
Table 75. Europe Glucagon Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Glucagon Sales Forecast by Country (2021-2026) & (K MT)
Table 77. Middle East & Africa Glucagon Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Glucagon Sales Forecast by Type (2021-2026) & (K MT)
Table 79. Global Glucagon Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Glucagon Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Glucagon Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Glucagon Sales Forecast by Application (2021-2026) & (K MT)
Table 83. Global Glucagon Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Glucagon Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Glucagon Revenue Market Share Forecast by Application (2021-2026)
Table 86. Novo Nordisk Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 87. Novo Nordisk Glucagon Product Offered
Table 88. Novo Nordisk Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 89. Novo Nordisk Main Business
Table 90. Novo Nordisk Latest Developments
Table 91. Eli Lilly Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 92. Eli Lilly Glucagon Product Offered
Table 93. Eli Lilly Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 94. Eli Lilly Main Business
Table 95. Eli Lilly Latest Developments
Table 96. Fresenius Kabi Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 97. Fresenius Kabi Glucagon Product Offered
Table 98. Fresenius Kabi Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 99. Fresenius Kabi Main Business
Table 100. Fresenius Kabi Latest Developments
Table 101. Torrent Labs Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 102. Torrent Labs Glucagon Product Offered
Table 103. Torrent Labs Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 104. Torrent Labs Main Business
Table 105. Torrent Labs Latest Developments
Table 106. Taj Pharmaceuticals Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 107. Taj Pharmaceuticals Glucagon Product Offered
Table 108. Taj Pharmaceuticals Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 109. Taj Pharmaceuticals Main Business
Table 110. Taj Pharmaceuticals Latest Developments
Table 111. Xeris Pharmaceuticals Basic Information, Glucagon Manufacturing Base, Sales Area and Its Competitors
Table 112. Xeris Pharmaceuticals Glucagon Product Offered
Table 113. Xeris Pharmaceuticals Glucagon Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2021E)
Table 114. Xeris Pharmaceuticals Main Business
Table 115. Xeris Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Glucagon
Figure 2. Glucagon Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glucagon Sales Growth Rate 2016-2026 (K MT)
Figure 7. Global Glucagon Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Glucagon Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Inject Glucagon
Figure 10. Product Picture of Nasal Glucagon
Figure 11. Global Glucagon Sales Market Share by Type in 2020
Figure 12. Global Glucagon Revenue Market Share by Type (2016-2021)
Figure 13. Glucagon Consumed in Emergency Kits
Figure 14. Global Glucagon Market: Emergency Kits (2016-2021) & (K MT)
Figure 15. Glucagon Consumed in General Use
Figure 16. Global Glucagon Market: General Use (2016-2021) & (K MT)
Figure 17. Glucagon Consumed in Diagnostic & Motility
Figure 18. Global Glucagon Market: Diagnostic & Motility (2016-2021) & (K MT)
Figure 19. Glucagon Consumed in Cardiogenic Shock
Figure 20. Global Glucagon Market: Cardiogenic Shock (2016-2021) & (K MT)
Figure 21. Glucagon Consumed in Others
Figure 22. Global Glucagon Market: Others (2016-2021) & (K MT)
Figure 23. Global Glucagon Sales Market Share by Application (2016-2021)
Figure 24. Global Glucagon Revenue Market Share by Application in 2020
Figure 25. Glucagon Revenue Market by Company in 2020 ($ Million)
Figure 26. Global Glucagon Revenue Market Share by Company in 2020
Figure 27. Global Glucagon Sales Market Share by Regions (2016-2021)
Figure 28. Global Glucagon Revenue Market Share by Region in 2020
Figure 29. Americas Glucagon Sales 2016-2021 (K MT)
Figure 30. Americas Glucagon Revenue 2016-2021 ($ Millions)
Figure 31. APAC Glucagon Sales 2016-2021 (K MT)
Figure 32. APAC Glucagon Revenue 2016-2021 ($ Millions)
Figure 33. Europe Glucagon Sales 2016-2021 (K MT)
Figure 34. Europe Glucagon Revenue 2016-2021 ($ Millions)
Figure 35. Middle East & Africa Glucagon Sales 2016-2021 (K MT)
Figure 36. Middle East & Africa Glucagon Revenue 2016-2021 ($ Millions)
Figure 37. Americas Glucagon Sales Market Share by Country in 2020
Figure 38. Americas Glucagon Revenue Market Share by Country in 2020
Figure 39. Americas Glucagon Sales Market Share by Type in 2020
Figure 40. Americas Glucagon Sales Market Share by Application in 2020
Figure 41. United States Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 42. Canada Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 43. Mexico Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 44. Brazil Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 45. APAC Glucagon Sales Market Share by Region in 2020
Figure 46. APAC Glucagon Revenue Market Share by Regions in 2020
Figure 47. APAC Glucagon Sales Market Share by Type in 2020
Figure 48. APAC Glucagon Sales Market Share by Application in 2020
Figure 49. China Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 50. Japan Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 51. Korea Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 52. Southeast Asia Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 53. India Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 54. Australia Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 55. Europe Glucagon Sales Market Share by Country in 2020
Figure 56. Europe Glucagon Revenue Market Share by Country in 2020
Figure 57. Europe Glucagon Sales Market Share by Type in 2020
Figure 58. Europe Glucagon Sales Market Share by Application in 2020
Figure 59. Germany Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 60. France Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 61. UK Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 62. Italy Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 63. Russia Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 64. Middle East & Africa Glucagon Sales Market Share by Country in 2020
Figure 65. Middle East & Africa Glucagon Revenue Market Share by Country in 2020
Figure 66. Middle East & Africa Glucagon Sales Market Share by Type in 2020
Figure 67. Middle East & Africa Glucagon Sales Market Share by Application in 2020
Figure 68. Egypt Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 69. South Africa Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 70. Israel Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 71. Turkey Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 72. GCC Country Glucagon Revenue Growth 2016-2021 ($ Millions)
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles